Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Jian Jun Li, Zong Liang Lu, Wen Rong Kou, Roberto Bolli, Zuo Chen, Yang Feng Wu, Xue Hai Yu, Yu Cheng Zhao

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)362-365
Number of pages4
JournalInternational Journal of Cardiology
Issue number3
StatePublished - Feb 9 2012


  • Abnormal liver test
  • Cardiovascular event
  • Myocardial infarction
  • Xuezhikang

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this